Pharsight

Drugs that contain Bupropion Hydrochloride; Dextromethorphan Hydrobromide

1. Auvelity patents expiration

AUVELITY's oppositions filed in EPO
Can you believe AUVELITY received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8569328 AXSOME Compositions and methods comprising tilidine or related compounds and dextromethorphan
Oct, 2033

(9 years from now)

US11524007 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11517542 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11517543 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11510918 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11382874 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11364233 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US9457025 AXSOME Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan
Nov, 2034

(10 years from now)

US10058518 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US9278095 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US9867819 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US9168234 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US9861595 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US9700553 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US11357744 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11344544 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US9486450 AXSOME Hydroxybupropion and related compounds as modulators of drug plasma levels
Nov, 2034

(10 years from now)

US9474731 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US9375429 AXSOME Compositions and methods comprising erythrohydroxybupropion and related compounds for improving the efficacy of dextromethorphan
Nov, 2034

(10 years from now)

US9421176 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US9408815 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US9763932 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US11311534 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US9205083 AXSOME Compositions and methods comprising erythrohydroxybupropion and related compounds for improving the efficacy of dextromethorphan
Nov, 2034

(10 years from now)

US9707191 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US10898453 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11433067 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11524008 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US9370513 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US9457023 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US9238032 AXSOME Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan
Nov, 2034

(10 years from now)

US11096937 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11298352 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10966941 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11298351 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11090300 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10894047 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10064857 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11291665 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US9700528 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US10105361 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US10105327 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphane and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US10092560 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US9968568 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US11478468 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11541048 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11541021 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11534414 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11779579 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11617728 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11617747 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11596627 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11497721 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11291638 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10786469 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US11253492 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10881657 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10874663 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10799497 AXSOME Combination of dextromethorphan and bupropion for treating depression
Nov, 2034

(10 years from now)

US11058648 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11273133 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10864209 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10806710 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10881624 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US10786496 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US11020389 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11185515 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10945973 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11285146 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11285118 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10596167 AXSOME Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan
Nov, 2034

(10 years from now)

US11439636 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US9314462 AXSOME Compositions and methods for increasing dextromethorphan plasma levels and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US9198905 AXSOME Compositions and methods for reducing dextrorphan plasma levels and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US11426401 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11426370 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11419867 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10772850 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11273134 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11253491 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11234946 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10548857 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US11229640 AXSOME Combination of dextromethorphan and bupropion for treating depression
Nov, 2034

(10 years from now)

US10874665 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10933034 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10251879 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10092561 AXSOME Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan
Nov, 2034

(10 years from now)

US10894046 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11191739 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10874664 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10080727 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US11197839 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11147808 AXSOME Method of decreasing the fluctuation index of dextromethorphan
Nov, 2034

(10 years from now)

US11207281 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11141416 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11141388 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11213521 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11129826 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US11123343 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10966974 AXSOME Bupropion as a modulator of drug activity
Nov, 2034

(10 years from now)

US10512643 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US10463634 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US10780066 AXSOME Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
Nov, 2034

(10 years from now)

US10780064 AXSOME Bupropion as a modulator of drug activity
Jan, 2040

(15 years from now)

US10966942 AXSOME Bupropion as a modulator of drug activity
Jan, 2040

(15 years from now)

US10925842 AXSOME Bupropion as a modulator of drug activity
Jan, 2040

(15 years from now)

US10940124 AXSOME Bupropion as a modulator of drug activity
Jan, 2040

(15 years from now)

US11896563 AXSOME Bupropion and dextromethorphan for reduction of suicide risk in depression patients
Dec, 2041

(17 years from now)

US11717518 AXSOME Bupropion dosage forms with reduced food and alcohol dosing effects
Jan, 2043

(18 years from now)

US11925636 AXSOME Bupropion dosage forms with reduced food and alcohol dosing effects
Jan, 2043

(18 years from now)

US11883373 AXSOME Treatment of depression in certain patient populations
Jan, 2043

(18 years from now)

US11730706 AXSOME Treatment of depression in certain patient populations
Jan, 2043

(18 years from now)

US11752144 AXSOME Compounds and combinations thereof for treating neurological and psychiatric conditions
Feb, 2043

(18 years from now)

US11839612 AXSOME Compounds and combinations thereof for treating neurological and psychiatric conditions
Mar, 2043

(18 years from now)

US11844797 AXSOME Combination of dextromethorphan and bupropion for treating depression
Apr, 2043

(18 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Aug 18, 2025

Market Authorisation Date: 18 August, 2022

Treatment: Dextromethorphan and bupropion in combination to treat major depressive disorder; Dextromethorphan and bupropion in combination to increase dextromethorphan plasma levels; Treatment of major depressiv...

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of AUVELITY before it's drug patent expiration?
More Information on Dosage

AUVELITY family patents

Family Patents